Intratumoral Co-Injection of NK Cells and NKG2A-Neutralizing Monoclonal Antibodies

Scientists found that intratumoral delivery of NK cells attained significant therapeutic effects only if co-injected with anti-NKG2A and anti-Qa-1b blocking monoclonal antibodies against solid mouse tumor models.